Skip to main content
Article thumbnail
Location of Repository

Preoperative neutrophil-lymphocyte ratio and outcome from coronary artery bypass grafting

By Patrick H. Gibson, Bernard L. Croal, Gary R. Small, Ada I. Ifezulike, George Gibson, Robert R. Jeffrey, Keith G. Buchan, Hussein El-Shafei, Graham S. Hillis and Brian Cuthbertson


Background: An elevated preoperative white blood cell count has been associated with a worse outcome after coronary artery bypass grafting (CABG). Leukocyte subtypes, and particularly the neutrophil-lymphocyte (N/L) ratio, may however, convey superior prognostic information. We hypothesized that the N/L ratio would predict the outcome of patients undergoing surgical revascularization. Methods: Baseline clinical details were obtained prospectively in 1938 patients undergoing CABG. The differential leukocyte was measured before surgery, and patients were followed-up 3.6 years later. The primary end point was all-cause mortality. Results: The preoperative N/L ratio was a powerful univariable predictor of mortality (hazard ratio [HR] 1.13 per unit, P < .001). In a backward conditional model, including all study variables, it remained a strong predictor (HR 1.09 per unit, P = .004). In a further model, including the European system for cardiac operative risk evaluation, the N/L ratio remained an independent predictor (HR 1.08 per unit, P = .008). Likewise, it was an independent predictor of cardiovascular mortality and predicted death in the subgroup of patients with a normal white blood cell count. This excess hazard was concentrated in patients with an N/L ratio in the upper quartile (>3.36). Conclusion: An elevated N/L ratio is associated with a poorer survival after CABG. This prognostic utility is independent of other recognized risk factors.Peer reviewedAuthor versio

Topics: Coronary Artery Bypass, Lymphocytes, Myocardial Ischemia, Neutrophils, RD Surgery
Publisher: Elsevier
Year: 2007
DOI identifier: 10.1016/j.ahj.2007.06.043
OAI identifier:

Suggested articles


  1. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies.
  2. (1996). Band neutrophil count and the presence and severity of coronary atherosclerosis.
  3. European system for cardiac operative risk evaluation predicts long-term survival in patients with coronary artery bypass grafting.
  4. (2006). EuroSCORE predicts immediate and late outcome after coronary artery bypass surgery. Ann Thorac Surg
  5. (2005). Expression of CD97 and adhesion molecules on circulating leukocytes in patients undergoing coronary artery bypass surgery. Eur Surg Res.
  6. Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials.
  7. Inflammation, atherosclerosis, and coronary heart disease.
  8. Leukocyte count and coronary heart disease: implications for risk assessment.
  9. Leukocyte count and risk of major coronary heart disease events.
  10. Leukocyte count as an independent predictor of recurrent ischemic events.
  11. Leukocyte count: a risk factor for coronary artery bypass graft mortality.
  12. Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene? Arterioscler Thromb Vasc Biol.
  13. Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study Investigators. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
  14. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.
  15. Neutrophil depletion reduces myocardial reperfusion morbidity. Ann Thorac Surg.
  16. Neutrophil infiltration of culprit lesions in acute coronary syndromes.
  17. Performance evaluation of the ADVIA 2120 hematology analyzer: an international multicenter clinical trial. Lab Hematol.
  18. (1998). Predictive power of the relative lymphocyte concentration in patients with advanced heart failure. Circulation.
  19. Predictive value of EuroSCORE on long term outcome in cardiac surgery patients: a single institution study.
  20. Preoperative white blood cell count and mortality and morbidity after coronary artery bypass grafting. Ann Thorac Surg.
  21. (2006). Preoperative white blood cell count is independently associated with higher perioperative cardiac enzyme release and increased 1-year mortality after coronary artery bypass grafting. Ann Thorac Surg.
  22. Preprocedural white blood cell count and death after percutaneous coronary intervention.
  23. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts.
  24. (1997). Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC)
  25. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction.
  26. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 substudy.
  27. Surgeon specific mortality in adult cardiac surgery: comparison between crude and risk stratified data.
  28. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction. Acad Emerg Med.
  29. The association between white blood cell count and acute myocardial infarction mortality in patients > or =65 years of age: findings from the cooperative cardiovascular project.
  30. The natural history of coronary heart disease: prognostic factors after recovery from myocardial infarction in 2789 men. The 5-year findings of the coronary drug project.
  31. The relationship between post-operative cardiac troponin I levels and outcome from cardiac surgery.
  32. Total and differential leukocyte counts as predictors of ischemic heart disease: the Caerphilly and Speedwell studies.
  33. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention.
  34. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease.
  35. Which white blood cell subtypes predict increased cardiovascular risk?
  36. White blood cell count and cardiovascular disease. Insights from the Framingham Study.
  37. White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]).

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.